Amazing presentation..
The key points being here that BOT will save and recover around 14-16% of the price of Sofda because they will be largely avoiding the wholesaler.
Given that 98% of physicians prescribe electronically, they will be able to get more of the product quicker (with insurance details ready to go).
Essentially, the net recovery of the Sofdra prescription will be higher and worth a lot more to Botanix than we first thought.
I can't see the market missing this for too much longer!
Ann: Euroz Hartleys Healthcare Forum Presentation, page-9
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.5¢ |
Change
-0.010(2.41%) |
Mkt cap ! $734.6M | |||
| Open | High | Low | Value | Volume |
| 42.0¢ | 42.5¢ | 39.5¢ | $3.680M | 8.989M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 297011 | 40.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.5¢ | 12027 | 3 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |